18 May 2013
Keywords: Cephalon, BioAssets, M&A, Etanercept, TNF
Article | 26 October 2009
US privately-held Cephalon has signed an option agreement to acquire BioAssets Development Corp (BDC). Under the terms of the deal, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 October 2009
27 October 2009
17 May 2013
© 2013 thepharmaletter.com